V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290005709 | 290004125 | 1.85 | 102.55 | Curative (C) | null | 2017-11-15 | OCTREOTIDE | N | Y | 290000041 | CAPECITABINE + CISPLATIN |
| 290005710 | 290004126 | 1.6 | 77 | Palliative (P) | 2017-08-18 | 2017-08-19 | GemCarbo Days 1+8 | 02 | null | 290000359 | LANREOTIDE |
| 290005711 | 290004127 | 2.05 | 0 | Curative (C) | 2009-11-22 | 2015-02-18 | FEC 60 or 75 | 02 | N | 290000664 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005712 | 290004127 | 1.56 | 48.8 | Disease modification (D) | 2018-08-27 | 2018-09-04 | Capecitabine 35days + RT | N | N | 290000664 | DABRAFENIB |
| 290005713 | 290007831 | 1.75 | 57 | Palliative (P) | 2019-09-19 | 2019-09-19 | CVD (skin) | 02 | N | 290002106 | LANREOTIDE |
| 290005714 | 290007831 | 1.8 | 58.7 | Palliative (P) | 2019-02-11 | 2019-02-12 | BENDAMUSTINE + RITUXIMAB | 1 | N | 290002106 | CAPECITABINE + RT |
| 290005715 | 290004128 | null | 70.3 | Palliative (P) | 2017-08-16 | 2017-08-16 | Trial Unspecified | 2 | N | 290005184 | LANREOTIDE |
| 290005716 | 290004129 | 1.55 | null | Palliative (P) | 2017-05-31 | 2017-06-15 | EOX | N | N | 290009412 | CARBOPLATIN + VINORELBINE |
| 290005717 | 290004129 | 1.68 | 57 | Curative (C) | 2015-05-03 | 2015-05-14 | CETUXIMAB + RT | Y | Y | 290009412 | PEMBROLIZUMAB |
| 290005718 | 290004130 | null | null | Palliative (P) | 2018-08-22 | 2018-08-28 | Gemcitabine weekly | 02 | N | 290009754 | CISPLATIN + FLUOROURACIL |
| 290005719 | 290004131 | 1.54 | 61.5 | Curative (C) | 2017-07-15 | 2017-07-20 | Fluorouracil 96hr infusion+R(4g/m2) | N | N | 290010297 | CETUXIMAB + RT |
| 290005720 | 290004132 | null | 74.6 | Palliative (P) | 2015-12-16 | 2015-12-16 | Fluorouricil + Folonic Acid (MdG) | N | N | 290010587 | EOX |
| 290005721 | 290006745 | 1.71 | 84 | Neo-adjuvant (N) | 2018-11-25 | 2018-12-05 | Carboplatin AUC 2 - 5 | 02 | N | 290010672 | CVD (NEUROENDOCRINE) |
| 290005722 | 290006745 | 1.7 | null | Palliative (P) | null | 2018-09-19 | EOX | N | N | 290010672 | GEMCITABINE |
| 290005723 | 290004133 | 0 | 59.5 | Curative (C) | null | 2014-12-30 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 290012031 | OCTREOTIDE |
| 290005724 | 290004133 | 1.78 | null | Curative (C) | null | 2018-08-14 | Carbo F | null | null | 290012031 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 290005725 | 290004134 | null | null | Disease modification (D) | 2017-06-21 | 2017-07-10 | GemCarbo Days 1+8 | N | N | 290015478 | CARBOPLATIN + RT |
| 290005726 | 290004134 | 1.68 | 80 | null | 2018-10-30 | 2018-11-18 | Cisplatin +Fluorouracil (3 wk) | N | Y | 290015478 | PACLITAXEL |
| 290005727 | 290004135 | 1.74 | 71.4 | Adjuvant (A) | 2015-09-23 | 2015-09-23 | Capecitabine | 02 | null | 290015961 | CISPLATIN + FLUOROURACIL |
| 290005728 | 290004136 | 1.66 | 78.9 | null | 2018-12-08 | 2018-12-29 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 290016398 | FLUOROURACIL |
| 290005729 | 290004137 | 1.78 | 57.7 | Palliative (P) | null | 2018-02-27 | Gemcitabine + Methylprednisolone | N | N | 290016522 | CETUXIMAB |
| 290005730 | 290004138 | 1.52 | 67 | Adjuvant (A) | 2013-10-01 | 2013-10-02 | CETUXIMAB + RT | N | N | 290016582 | DOCETAXEL |
| 290005731 | 290004138 | 1.77 | 78.2 | Curative (C) | 2014-08-21 | 2014-08-30 | CVD (Neuroendocrine) | 02 | null | 290016582 | TRIAL |
| 290005732 | 290004138 | 1.78 | 110.7 | Palliative (P) | 2017-06-14 | 2017-06-28 | BENDAMUSTINE + RITUXIMAB | N | N | 290016582 | CETUXIMAB |
| 290005733 | 290004138 | 1.5 | 67.2 | Adjuvant (A) | 2017-05-28 | 2017-05-28 | EOX | 02 | Y | 290016582 | OCTREOTIDE |
| 290005734 | 290008387 | null | null | Palliative (P) | 2018-04-18 | 2018-04-30 | CETUXIMAB | N | N | 290019219 | CARBO + FLUOROURACIL |
| 290005735 | 290008387 | 1.66 | 46.2 | Palliative (P) | 2017-05-06 | 2017-05-06 | CISPLATIN + FLUOROURACIL | 2 | Y | 290019219 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 290005736 | 290008387 | 1.83 | 56.6 | Adjuvant (A) | null | 2016-05-18 | Capecitabine | null | null | 290019219 | PLATO TRIAL |
| 290005737 | 290008387 | 1.59 | 67 | Curative (C) | 2010-11-17 | 2016-02-28 | Capecitabine 35days + RT | 02 | N | 290019219 | CISPLATIN + VINORELBINE |
| 290005738 | 290004139 | null | 56.8 | Disease modification (D) | 2019-06-22 | 2019-06-24 | Mitomycin Intravesical | 02 | N | 290021495 | PEMBROLIZUMAB |
| 290005739 | 290004139 | 1.6 | 75.05 | Adjuvant (A) | 2018-04-18 | 2018-05-16 | LANREOTIDE | 01 | N | 290021495 | LANREOTIDE |
| 290005740 | 290004140 | 1.73 | 61 | Palliative (P) | 2017-09-26 | 2017-09-26 | CARBOPLATIN + RT | 02 | N | 290023774 | LANREOTIDE |
| 290005741 | 290004141 | 1.78 | 98.8 | null | 2019-02-19 | 2019-04-14 | GEMCITABINE | N | Y | 290024058 | ECX |
| 290005742 | 290004141 | 1.5 | 0 | Palliative (P) | 2015-04-15 | 2015-04-15 | Capecitabine 35days + RT | N | N | 290024058 | CARBOPLATIN |
| 290005743 | 290004141 | 1.59 | 68.6 | Adjuvant (A) | 2018-02-13 | 2018-02-26 | OCTREOTIDE | 2 | N | 290024058 | MITOMYCIN |
| 290005744 | 290004141 | null | 65.6 | Palliative (P) | 2018-12-02 | 2018-12-02 | EOX | N | N | 290024058 | CAPECITABINE + STREPTOZOCIN |
| 290005745 | 290008388 | 1.8 | 50 | Palliative (P) | 2015-08-25 | 2015-09-13 | LANREOTIDE | 02 | N | 290024779 | OCTREOTIDE |
| 290005746 | 290008388 | 1.74 | null | Palliative (P) | 2019-10-08 | 2019-10-13 | LANREOTIDE | N | N | 290024779 | CAPECITABINE + RT |
| 290005747 | 290004142 | 1.54 | 37.4 | Adjuvant (A) | 2017-10-28 | 2017-10-30 | CETUXIMAB + RT | N | N | 290025623 | RCEOP |
| 290005748 | 290004143 | 1.68 | 64.7 | Palliative (P) | 2017-11-05 | 2017-11-25 | CISPLATIN + VINORELBINE | N | N | 290025844 | MITOMYCIN |
| 290005749 | 290004143 | null | null | Disease modification (D) | null | 2016-08-08 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 290025844 | CARBOPLATIN + ETOPOSIDE |
| 290005750 | 290004144 | 1.63 | 75.5 | Neo-adjuvant (N) | 2013-10-31 | 2013-10-31 | CAPECITABINE + RT | 02 | N | 290026607 | CAPECITABINE + RT |
| 290005751 | 290004145 | 1.68 | 80.4 | Palliative (P) | 2018-07-15 | 2018-07-21 | Azacitidine | N | N | 290027190 | MELPHALAN |
| 290005752 | 290004145 | 1.8 | 50 | Palliative (P) | 2019-12-10 | 2019-12-26 | Cisplatin + Fluorouracil + RT 5day | N | N | 290027190 | CETUXIMAB + RT |
| 290005753 | 290004145 | null | 96.85 | null | 2018-04-05 | 2018-04-08 | Fluouracil continuous infusion | 2 | Y | 290027190 | CISPLATIN + ETOPOSIDE |
| 290005754 | 290004146 | 1.64 | 90.8 | Palliative (P) | 2018-11-16 | 2018-11-27 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 290027618 | LANREOTIDE |
| 290005755 | 290004147 | 1.77 | 87.2 | Palliative (P) | 2018-04-30 | 2018-05-08 | Carboplatin + Pemetrexed | N | N | 290027789 | CARBO + FLUOROURACIL |
| 290005756 | 290004148 | 1.81 | 83.6 | Neo-adjuvant (N) | 2019-06-13 | 2019-06-13 | PLATO Trials | N | Y | 290004893 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005757 | 290004149 | 1.54 | null | Curative (C) | 2018-01-14 | 2018-01-25 | OCTREOTIDE | N | N | 290016522 | CAPECITABINE + GEMCITABINE |
| 290005758 | 290004149 | 1.62 | 53 | Adjuvant (A) | 2018-11-29 | 2018-12-27 | EOX | 2 | N | 290016522 | CARBOPLATIN |